Principal Scientist, Immuno Oncology – Translational Development
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries – and growing – we look for talented people to grow our business, advance our science and contribute to our unique culture.
The candidate will have responsibility for directing the scientific aspects of preclinical oncology drug development programs and translational medicine correlative studies in Immune Oncology. The successful candidate will be responsible for contributing to translational development strategies for Celgene’s drugs. Expertise in developing and qualifying biomarkers for clinical trials, and strong knowledge in immunology and tumor biology is required. The individual will supervise laboratory based experiments as well as work with contract research organizations and internal and external collaborators. Activities include carrying out mechanism of action studies, biomarker identification, and generation of data that supports patient stratification and the pharmacodynamic evaluation of drugs in the clinical setting.
Responsibilities:
In-depth knowledge of fundamentals of immunology, immune oncology, and tumor biology in solid and hematological malignancies
Utilization of translational based approaches to develop new concepts and mechanism of action hypotheses identifying distinguishing characteristic of Celgene compounds alone and in combination with other therapies
Knowledge of biomarker discovery…cont.
-See more at http://www.hirelifescience.com/principal-scientist-immuno-oncology-translational-development/seattle-wa-98101-693709/?p=p&submission=2
